Purchase Order 75N95D20P00148

This is a firm fixed-price delivery order contract awarded by the National Institute on Aging (NIA), a civilian federal agency, to Scantox Neuro GMBH, a for-profit organization based in Austria. The contract, valued at $858,106.08, is for the experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses. This work supports ongoing NIA research initiatives such as the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) and PREVENT-AD studies....

The National Institute on Aging (NIA), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded an $852,000 firm fixed price delivery order contract to The Bioteam, Inc. (Bioteam) under the company's Multiple Award Schedule contract vehicle. Bioteam will perform an Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) Data Ecosystem Landscape Assessment for NIA through November 15, 2023 from its place of performance...

This is a firm-fixed-price purchase order award to Alamar Biosciences, Inc. by the National Institute on Aging (NIA), a civilian agency, for $247,000.00. The contract is for providing proteomic analysis services, including the NULISAseq CNS Disease Panel 120 assay, next-generation sequencing, and bioinformatic support for 1,118 plasma samples. The purpose is to identify biomarkers that can be used to classify and stage Alzheimer's disease. This award is not associated with a set-aside and is the...

The National Institute of Neurological Disorders and Stroke awarded a purchase order to 10X Genomics, Inc. on December 28, 2020, for $11,864.00 under firm fixed price terms. Performance occurs in Pleasanton, California. The purchase order calls for genomic analysis platforms, reagents, or related consumables aligned with the vendor's product portfolio of single-cell and spatial transcriptomics technologies supporting neurological disease research. Ultimate completion was scheduled for January...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to the National University of Singapore. The $169,830 contract is for testing the efficacy of candidate Alzheimer's disease treatments in rescuing impaired hippocampal synaptic plasticity. This is part of the NIH's Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study, which is testing approximately 20 FDA-approved drugs to...

The National Institutes of Health National Institute on Aging awarded a $294,880 firm-fixed price purchase order to 10X Genomics, Inc. for long read sequencing kits. The solicitation requested quotations for these products to support gene expression analysis for the agency's Center for Alzheimer's Disease and Related Dementias neurodegenerative disease research. Evaluation criteria included technical capability, price, and past performance. This requirement was set aside for small businesses...

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to Sage Scientific LLC for $24,399.00 on February 5, 2021. The awardee is a small disadvantaged business. Work is performed in Beverly, Massachusetts. The order procures specialized scientific equipment supporting neurological and neuroscience research. The contract is firm fixed price with an ultimate completion date of February 5, 2021.</p>

This firm fixed price purchase order was awarded by the National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, to 10X Genomics, Inc. for $80,019.05. The contract is for single-cell multiomic assays to be used to map the epigenetic and transcriptomic signatures in peripheral blood mononuclear cells from participants in the Baltimore Longitudinal Study on Aging. This work aims to identify peripheral signatures that could predict the onset of cognitive...

The National Institute on Drug Abuse awarded a purchase order to Somalogic Operating Co., Inc. valued at $1,083,600.02 on September 1, 2021 for discovery-based proteomics analysis of archived plasma samples from the Baltimore Longitudinal Study of Aging (BLSA) to identify molecular pathways accelerating pathological phosphorylation of tau in individuals at risk for Alzheimer's disease. Work is performed in Boulder, Colorado. The order calls for aptamer-based proteomic assays on approximately...

This non-competitive purchase order for $197,979.19 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to Quanterix Corporation of Billerica, Massachusetts. The firm fixed price order is for the purchase of Quanterix assay kits including the Neurology 3-Plex A Advantage Kit, pTau-181 Advantage Kit, P-Tau 231 Simoa Assay Kit, discs, buffers, and sealing oil to be used with the Simoa HD-X Analyzer currently owned by NIA. The...